Application 089308
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | Injectable; Injection | EQ 25MG BASE/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methotrexate Sodium | METHOTREXATE SODIUM | Elite Laboratories, Inc. | 89c05ea3-3be1-46dd-b112-29c436fd7289 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | Methotrexate Sodium METHOTREXATE SODIUM |
| Methotrexate | METHOTREXATE SODIUM | Sun Pharmaceutical Industries, Inc. | 8f1260de-b60c-4f0e-8af6-0e957b0a281b | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE SODIUM |
| Methotrexate Sodium | METHOTREXATE SODIUM | Hikma Pharmaceuticals USA Inc. | d71b1856-99d8-4a9e-9189-f87b6675f80a | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Methotrexate Sodium METHOTREXATE SODIUM |
| Methotrexate | METHOTREXATE SODIUM | Fresenius Kabi USA, LLC | ec476b11-0b3c-4139-b1eb-a3daa76bc271 | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE SODIUM |
| Methotrexate | METHOTREXATE SODIUM | Bryant Ranch Prepack | c7592288-ac24-46c6-8cec-9abe23d7e81e | 2023-12-07 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE SODIUM |
| Methotrexate | METHOTREXATE SODIUM | Fresenius Kabi USA, LLC | b585f621-f6c9-4735-ab61-bd1b401f3df0 | 2021-03-24 | Boxed warning, Adverse reactions | METHOTREXATE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.